Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy

Allergic reactions are common reasons for withdrawal of oxcarbazepine treatment in patients with epilepsy. However, some patients are not responsive to other antiseizure medications. Herein, two pediatric patients with epilepsy and allergic to oxcarbazepine to whom oxcarbazepine therapy was successf...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lingyan, Wang, Zhiliang, Yu, Zhenwei, Feng, Jianhua, Dai, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351383/
https://www.ncbi.nlm.nih.gov/pubmed/34181315
http://dx.doi.org/10.1002/acn3.51415
_version_ 1783735962953580544
author Yu, Lingyan
Wang, Zhiliang
Yu, Zhenwei
Feng, Jianhua
Dai, Haibin
author_facet Yu, Lingyan
Wang, Zhiliang
Yu, Zhenwei
Feng, Jianhua
Dai, Haibin
author_sort Yu, Lingyan
collection PubMed
description Allergic reactions are common reasons for withdrawal of oxcarbazepine treatment in patients with epilepsy. However, some patients are not responsive to other antiseizure medications. Herein, two pediatric patients with epilepsy and allergic to oxcarbazepine to whom oxcarbazepine therapy was successfully reintroduced are described. The reintroduction strategy used in this study was simple, feasible, and suitable for the reintroduction of oxcarbazepine in pediatric patients with epilepsy.
format Online
Article
Text
id pubmed-8351383
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83513832021-08-15 Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy Yu, Lingyan Wang, Zhiliang Yu, Zhenwei Feng, Jianhua Dai, Haibin Ann Clin Transl Neurol Case Study Allergic reactions are common reasons for withdrawal of oxcarbazepine treatment in patients with epilepsy. However, some patients are not responsive to other antiseizure medications. Herein, two pediatric patients with epilepsy and allergic to oxcarbazepine to whom oxcarbazepine therapy was successfully reintroduced are described. The reintroduction strategy used in this study was simple, feasible, and suitable for the reintroduction of oxcarbazepine in pediatric patients with epilepsy. John Wiley and Sons Inc. 2021-06-28 /pmc/articles/PMC8351383/ /pubmed/34181315 http://dx.doi.org/10.1002/acn3.51415 Text en © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Study
Yu, Lingyan
Wang, Zhiliang
Yu, Zhenwei
Feng, Jianhua
Dai, Haibin
Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
title Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
title_full Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
title_fullStr Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
title_full_unstemmed Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
title_short Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
title_sort reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351383/
https://www.ncbi.nlm.nih.gov/pubmed/34181315
http://dx.doi.org/10.1002/acn3.51415
work_keys_str_mv AT yulingyan reintroductionofoxcarbazepineafterallergicreactionintwopediatricpatientswithepilepsy
AT wangzhiliang reintroductionofoxcarbazepineafterallergicreactionintwopediatricpatientswithepilepsy
AT yuzhenwei reintroductionofoxcarbazepineafterallergicreactionintwopediatricpatientswithepilepsy
AT fengjianhua reintroductionofoxcarbazepineafterallergicreactionintwopediatricpatientswithepilepsy
AT daihaibin reintroductionofoxcarbazepineafterallergicreactionintwopediatricpatientswithepilepsy

Ejemplares similares